Remove 2013 Remove Patients Remove Prescription
article thumbnail

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

Rapamycin was approved in 1999 and it’s also worth noting their Phase II was a tiny patient population. ” Research shows that cancer patients are more likely to declare bankruptcy than the average person. According to research, cancer patients are 2.65 The drug is rapamycin in a new albumin coating.

article thumbnail

The rise of prescription drug abuse and drug diversion

pharmaphorum

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Drug diversion is the channelling of prescription drugs from a medical source into the illegal market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Constipation Patients Are Suffering in Silence—Here’s How to Help Them

PM360

1 Yet, most patients haven’t tried prescription therapies, a discovery Phreesia Life Sciences made after surveying 6,780 adults age 18 and older who previously had been diagnosed with or treated for constipation as they checked in for their doctors’ appointments. Address Patients’ Quality of Life. Why the disconnect?

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. For DTC, the model will become one of collaboration with patients as they help them navigate the complex system of American healthcare. ASH Clinical News takes it a step further.

Pharma 210
article thumbnail

AbbVie CEO looks like a fool before Congress

World of DTC Marketing

SUMMARY: “You’re spending all this money to make sure you make money rather than spending money to… help patients,” the California congresswoman told AbbVie’s, Richard Gonzalez. Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. But it get worse.

Pharma 181
article thumbnail

Using Behavioral Science to MOVE—Not Nudge—Patients to Take Their Medications

PM360

Increased adherence to medication represents the single biggest opportunity for the pharmaceutical industry to help improve patient outcomes while also growing revenues and reducing health costs across the wider system. Of those who do, 40% still fail to get a second refill. Addressing the Complex Behaviors Behind Non-Adherence.

Patients 105
article thumbnail

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Medgadget

The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution.